Please login to the form below

Not currently logged in
Email:
Password:

Organ allocation system to be reviewed

The rules governing organ transplants for NHS patients and non-UK EU residents are to be reviewed

The rules governing organ transplants for NHS patients and non-UK EU residents are to be reviewed.

Health Secretary Alan Johnson announced the review, which aims to ensure public confidence in the fairness of the system that sees many organs from deceased UK donors transplanted into non-UK resident EU nationals each year.

"We are aware that some people resident in other countries within the European Union needing transplants are being referred to the UK. This had led to accusations of priority being given to non-UK patients. We want to optimise the availability of organs for transplant for NHS patients and ensure public confidence in the fairness and transparency of the organ allocation system in the UK," said Johnson.

As well as reassuring the public about the integrity of the UK transplant programme, the review will enable individual transplant centres to review their policies ensuring the needs of UK patients are met within the framework of European law.

Chair of the former Organ Donation Taskforce, Elisabeth Buggins will lead the review. Commenting on her role, she said: "I recognise that this is a complex and sensitive area. It is important to be able to build the confidence of the public in the integrity of the systems that determine how precious donated organs are allocated to individual patients, and to provide clear guidance to the transplant community."

11th March 2009

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics